OPC Pharmaceutical JSC (HOSE:OPC)

OPC Pharmaceutical JSC Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,057,743	968,576	1,004,887	1,171,614	1,123,728	965,591
Revenue Growth (YoY)	11.20%	-3.61%	-14.23%	4.26%	16.38%	-2.40%
Cost of Revenue	565,259	522,458	526,456	637,906	643,499	572,130
Gross Profit	492,484	446,118	478,431	533,708	480,229	393,460
Selling, General & Admin	361,344	311,684	332,311	355,073	313,516	257,049
Operating Expenses	361,344	311,684	332,311	355,073	313,516	257,049
Operating Income	131,140	134,434	146,120	178,636	166,713	136,411
Interest Expense	-	-	-334.55	-925.2	-4,819	-5,490
Interest & Investment Income	11,874	8,335	15,854	7,813	3,707	4,391
Earnings From Equity Investments	1,574	1,535	838.45	797.74	172.88	1,877
Currency Exchange Gain (Loss)	929.52	448.73	555.41	279.37	360.84	622.41
Other Non Operating Income (Expenses)	-6,647	-7,627	-7,710	-6,677	-6,894	-5,034
EBT Excluding Unusual Items	138,870	137,126	155,323	179,924	159,241	132,778
Pretax Income	138,870	137,126	155,323	179,924	159,241	132,778
Income Tax Expense	29,063	27,672	33,004	37,530	35,878	29,871
Earnings From Continuing Operations	109,807	109,454	122,319	142,394	123,363	102,907
Minority Interest in Earnings	-1,009	-2,394	-84.74	-266.22	3,014	2,884
Net Income	108,798	107,060	122,234	142,128	126,377	105,791
Preferred Dividends & Other Adjustments	18,619	16,059	18,677	14,010	13,416	10,993
Net Income to Common	90,179	91,001	103,557	128,118	112,961	94,798
Net Income Growth	7.60%	-12.41%	-14.00%	12.46%	19.46%	4.81%
Shares Outstanding (Basic)	64	64	64	64	64	64
Shares Outstanding (Diluted)	64	64	64	64	64	64
Shares Change (YoY)	-	-	-	-	-0.00%	-
EPS (Basic)	1407.93	1420.76	1616.80	2000.25	1763.61	1480.03
EPS (Diluted)	1407.93	1420.76	1616.80	2000.00	1763.61	1480.03
EPS Growth	3.27%	-12.13%	-19.16%	13.40%	19.16%	4.88%
Free Cash Flow	62,581	12,147	243,317	28,688	181,809	93,340
Free Cash Flow Per Share	977.04	189.65	3798.80	447.90	2838.51	1457.27
Dividend Per Share	-	-	1500.000	1500.000	-	1244.813
Gross Margin	46.56%	46.06%	47.61%	45.55%	42.73%	40.75%
Operating Margin	12.40%	13.88%	14.54%	15.25%	14.84%	14.13%
Profit Margin	8.53%	9.40%	10.30%	10.94%	10.05%	9.82%
Free Cash Flow Margin	5.92%	1.25%	24.21%	2.45%	16.18%	9.67%
EBITDA	152,730	156,652	169,015	201,454	189,215	158,152
EBITDA Margin	14.44%	16.17%	16.82%	17.20%	16.84%	16.38%
D&A For EBITDA	21,590	22,218	22,895	22,819	22,502	21,740
EBIT	131,140	134,434	146,120	178,636	166,713	136,411
EBIT Margin	12.40%	13.88%	14.54%	15.25%	14.84%	14.13%
Effective Tax Rate	20.93%	20.18%	21.25%	20.86%	22.53%	22.50%
Revenue as Reported	1,057,743	968,576	1,004,887	1,171,614	1,123,728	965,591
Advertising Expenses	-	43,302	51,343	48,858	40,148	17,880

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.